Validation of 3D bioprinted h-VIOS platform for ADME-toxicology studies
April 2, 2025
Systemic Bio LLC has developed a 3D bioprinted human Vascularized Integrated Organ System (h-VIOS) platform that better recapitulates the native-like liver architecture and vascularization, integrating PHHs and non-parenchymal cells.